Related / Contacts

Related / News

2011 brought continued progress for NNIT. Turnover increased to DKK 1.8 billion and operating profit before tax was DKK 194 million. Moreover, in the past year, NNIT increased its workforce and strengthened its market position via more global sourcing and investment in new IT systems and new headquarters.

Read about the four strategic focus areas in the NNIT 2020 strategy. Also meet Merete and Jan, who are helping to make the Danish health system more effective. And we pass the word to the US, asking Sam to give his impression of NNIT seen from a US perspective. We also pass through the Czech Republic and take a look at the country from above with the skydiver Stefan.

Meet the team who work behind lock and key at the data centre. You can hear a major customer’s views
on working with us. You can read about Peter, who organises a race to raise funds for vulnerable minorities in Vesterbro. And much more.

Read about the general international growth strategy, the importance of our life science focus and
about how we go to market – known as 1-10-100. We have also checked in at our offices in
both NNIT China and NNIT US to see what international growth means there on an everyday
basis. What do our international customers say?

Read about Oliver, an IT consultant by day and hard rock singer by night. You can also read about Ada and Jesper, who work across cultural borders. And you can find out why Jess said ‘yes’
to becoming Senior Vice President.

The latest version of the integration tool SAP PO is a pure Java solution that runs faster and provides new opportunities for communication with EDI systems. The new version of SAP Process Orchestration is both smarter and faster than its predecessor. Companies must consider a number of aspects before deciding on an upgrade, advises SAP expert Peter Kreiner from NNIT.

Drug makers are facing an ever-increasing challenge as more countries implement serialization and tracking regulations and set compliance deadlines in an effort to ensure the safety and quality of prescription drugs being sold within their borders. Complying with regulations coming into effect will be a demanding task due to a lack of global harmonization.

Change is afoot for pharmaceutical companies, with new serialisation legislation on the agenda. To help stem the problem of drug counterfeiting, they will be required to adopt a unique serial number labelling system and adapt their business processes accordingly. How can companies derive real business value from the investments they are now required to make?

Related / Documents

Read an interview with our new CFO, workorking hard at exploring whether becoming publicly listed is the right path for NNIT. Read, too, about our new and larger Aarhus office, a good picture of our expansion among Jutland-based industrial businesses. And read about our colleagues in the USA who are fighting a brave fight to solidly plant the NNIT flag in the American life sciences market.

Read about the general international growth strategy, the importance of our life science focus and
about how we go to market – known as 1-10-100. We have also checked in at our offices in
both NNIT China and NNIT US to see what international growth means there on an everyday
basis. What do our international customers say?

Meet the team who work behind lock and key at the data centre. You can hear a major customer’s views
on working with us. You can read about Peter, who organises a race to raise funds for vulnerable minorities in Vesterbro. And much more.